HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Fillmore Selected Research

Tuberculosis (Tuberculoses)

1/2023Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.
1/2016PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Fillmore Research Topics

Disease

3Granuloma
01/2023 - 01/2016
2Tuberculosis (Tuberculoses)
01/2023 - 01/2016
1Infections
01/2016

Drug/Important Bio-Agent (IBA)

1Moxifloxacin (Avelox)FDA Link
01/2023
1Anti-Bacterial Agents (Antibiotics)IBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2016
1Interleukin-17 (Interleukin 17)IBA
01/2016
1Neutralizing AntibodiesIBA
01/2016
1Interleukin-2 (IL2)IBA
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016